Director, Clinical Development Systems
Quick Summary
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies.
Position Overview
The Director, Clinical Development Systems (CDS) provides strategic and operational leadership of Immunome’s clinical systems, responsible for advancing the Development function’s systems strategy, roadmap, and implementation plans, including Trial Master File (TMF), Clinical Trial Management System (CTMS), reporting, AI-enabled dashboards, and KPI analytics.
The Director partners with Development teams, IT, Quality, Procurement, Finance, and external vendors to establish connected, inspection-ready, and business-aligned clinical systems capabilities to enable end-to-end visibility across studies, countries, sites, milestones, documents, issues, risks, clinical monitoring activities, enrollment, cycle times, and trial performance indicators.
The Director will also lead a high-performing CDS team to partner with Study Teams on trial delivery, oversee day-to-day vendor management, and establish clinical systems best practices.
Responsibilities
Requirements
~1 min readImmunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish).
Location & Eligibility
Listing Details
- Posted
- August 6, 2026
- First seen
- August 6, 2026
- Last seen
- August 7, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 79%
- Scored at
- August 6, 2026
Signal breakdown
Please let Immunomeinc know you found this job on Jobera.
3 other jobs at Immunomeinc
View all →Explore open roles at Immunomeinc.
Similar Development jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.